- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 08, 2024, 06:37:14 PM
- Local Time:
- May 19, 2024, 11:21:40 PM
- Last Active:
- May 08, 2024, 09:29:02 PM
Signature:
In spite of the guaranteeing throughout vitro along with preclinical results, double PI3K/Akt/mTOR inhibitor NVP-BEZ235, along with ATP-competitive mT